###begin article-title 0
Notch activates cell cycle reentry and progression in quiescent cardiomyocytes
###end article-title 0
###begin p 1
###xml 32 52 32 52 <email xmlns:xlink="http://www.w3.org/1999/xlink">mmercola@burnham.org</email>
Correspondence to Mark Mercola: mmercola@burnham.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
The inability of heart muscle to regenerate by replication of existing cardiomyocytes has engendered considerable interest in identifying developmental or other stimuli capable of sustaining the proliferative capacity of immature cardiomyocytes or stimulating division of postmitotic cardiomyocytes. Here, we demonstrate that reactivation of Notch signaling causes embryonic stem cell-derived and neonatal ventricular cardiomyocytes to enter the cell cycle. The proliferative response of neonatal ventricular cardiomyocytes declines as they mature, such that late activation of Notch triggers the DNA damage checkpoint and G2/M interphase arrest. Notch induces recombination signal-binding protein 1 for Jkappa (RBP-Jkappa)-dependent expression of cyclin D1 but, unlike other inducers, also shifts its subcellular distribution from the cytosol to the nucleus. Nuclear localization of cyclin D1 is independent of RBP-Jkappa. Thus, the influence of Notch on nucleocytoplasmic localization of cyclin D1 is an unanticipated property of the Notch intracellular domain that is likely to regulate the cell cycle in multiple contexts, including tumorigenesis as well as cardiogenesis.
###end p 3
###begin p 4
Victor M. Campa and Raquel Gutierrez-Lanza's present address is Instituto de Biologia y Genetica Molecular, Universidad de Valladolid, 47003 Valladolid, Spain.
###end p 4
###begin p 5
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
###xml 427 430 <span type="species:ncbi:10116">rat</span>
Abbreviations used in this paper: betaGal, beta-galactosidase; BIO, 6-bromoindirubin-3'-oxime; CRM1, chromosome region maintenance 1; DBM, DNA-binding mutant; GSK3beta, glycogen synthase kinase-3beta; Hes1, hairy and enhancer of split 1; His3, histone 3; ICD, intracellular domain; LMB, leptomycin B; mESC, mouse embryonic stem cell; MLC2V, myosin light chain 2V; NMVC, neonatal mouse ventricular cardiomyocyte; NRVC, neonatal rat ventricular cardiomyocyte; P, postnatal day; PHE, phenylephrine; Rb, retinoblastoma protein; RBP-Jkappa, recombination signal-binding protein 1 for Jkappa.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 128 150 128 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Winick and Noble, 1965</xref>
###xml 152 167 152 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Li et al., 1996</xref>
###xml 169 188 169 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Burton et al., 1999</xref>
###xml 651 669 651 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Rones et al., 2000</xref>
###xml 671 690 671 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Loomes et al., 2002</xref>
###xml 692 714 692 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Rutenberg et al., 2006</xref>
###xml 716 737 716 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Watanabe et al., 2006</xref>
###xml 739 763 739 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Grego-Bessa et al., 2007</xref>
###xml 765 789 765 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Niessen and Karsan, 2007</xref>
###xml 1025 1044 1025 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Dallas et al., 2005</xref>
###xml 1046 1062 1046 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Fre et al., 2005</xref>
###xml 1064 1086 1064 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Mammucari et al., 2005</xref>
###xml 1088 1107 1088 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">van Es et al., 2005</xref>
###xml 1183 1202 1183 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Kohler et al., 2004</xref>
###xml 1204 1221 1204 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Raya et al., 2004</xref>
###xml 1223 1238 1223 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Su et al., 2006</xref>
###xml 1240 1264 1240 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Nakamura and Chiba, 2007</xref>
###xml 1266 1276 1266 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Poss, 2007</xref>
Cardiomyocytes actively divide during embryonic development but exit the cell cycle and stop proliferating shortly after birth (Winick and Noble, 1965; Li et al., 1996; Burton et al., 1999). The incapacity of adult cardiomyocytes to divide underlies the inability of the heart muscle to regenerate after an injury, such as a myocardial infarction, that frequently leads to overload and heart failure. Notch signaling is normally active in the embryonic heart of multiple species, where it influences cell fate and morphogenesis, including within the early myocardial field, atrioventricular canal myocardium and cushions, and in the ventricular wall (Rones et al., 2000; Loomes et al., 2002; Rutenberg et al., 2006; Watanabe et al., 2006; Grego-Bessa et al., 2007; Niessen and Karsan, 2007). In addition to controlling cell fate, several studies indicate that Notch influences tissue formation and morphogenesis during development by regulating the balance between a progenitor or precursor pool and differentiating progeny (Dallas et al., 2005; Fre et al., 2005; Mammucari et al., 2005; van Es et al., 2005). In principal, a similar process could contribute to tissue regeneration (Kohler et al., 2004; Raya et al., 2004; Su et al., 2006; Nakamura and Chiba, 2007; Poss, 2007). Because the signals that control fetal and early neonatal cardiomyocyte replication and the subsequent postnatal withdrawal from cell cycle are unclear, we explored whether Notch reactivation might trigger and sustain the cell cycle of neonatal dividing and quiescent cardiomyocytes.
###end p 7
###begin p 8
###xml 188 205 184 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Schweisguth, 2004</xref>
###xml 672 689 656 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Bush et al., 2001</xref>
###xml 691 710 675 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Ramain et al., 2001</xref>
###xml 999 1028 979 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Ronchini and Capobianco, 2001</xref>
Binding to the transmembrane Delta or Jagged ligands on a signaling cell triggers a gamma-secretase-dependent proteolytic cleavage of transmembrane Notch receptors on the responding cell (Schweisguth, 2004). Cleavage releases the Notch intracellular domain (ICD) that complexes with the transcription factor recombination signal-binding protein 1 for Jkappa (RBP-Jkappa; also known as CSL [CBF1, Su(H), LAG-1]) to activate transcription of downstream targets. In addition to this canonical cascade, RBP-Jkappa-independent signaling has recently been demonstrated to occur through various intermediaries, including the Dishevelled (Dsh) protein required for Wnt signaling (Bush et al., 2001; Ramain et al., 2001). Despite its involvement in tumorigenesis and tissue morphogenesis, details of the mechanisms that might link Notch signaling to cell cycle control are unclear, although the complex containing the Notch ICD and RBP-Jkappa directly activates transcription of the cyclin D1 gene promoter (Ronchini and Capobianco, 2001).
###end p 8
###begin p 9
###xml 660 682 652 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Leong and Karsan, 2006</xref>
###xml 684 702 676 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Miele et al., 2006</xref>
###xml 722 725 714 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 823 824 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
We found that activation of the Notch pathway in mouse embryonic stem cell (mESC)-derived and early neonatal cardiomyocytes induced cyclin D expression and stimulated cell cycle entry, mitosis, and cell division. Cell cycle progression involved the RBP-Jkappa-dependent induction of cyclin D1, which led to its cytosolic accumulation. Translocation to the nucleus, retinoblastoma protein (Rb) phosphorylation, and cell cycle entry, however, specifically required the Notch ICD. This constitutes a novel function for the ICD that might account for aspects of RBP-Jkappa-independent signaling that have been implicated recently in tumorigenesis (for reviews see Leong and Karsan, 2006; Miele et al., 2006). Interestingly, N2ICD induced older cardiomyocytes to enter cell cycle; however, DNA damage checkpoint activation and G2/M interphase arrest followed, most likely reflecting an intrinsic barrier to replication of mature cardiomyocytes that might serve a beneficial role in the mature heart by preventing mitotic catastrophe and apoptosis in response to mitogenic stimuli. Together, these results point to a role for Notch in the expansion of cardiomyocyte progenitor or precursor pools needed for heart growth during development and potentially during regeneration after injury in the adult.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Notch induces quiescent cardiomyocytes to reenter the cell cycle
###end title 11
###begin p 12
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 91 110 91 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Burton et al., 1999</xref>
###xml 172 175 172 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 182 185 182 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 291 292 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 375 394 375 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A, C, and D</xref>
###xml 524 539 518 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B and D</xref>
###xml 547 550 541 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 587 588 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 611 630 605 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E, G, and H</xref>
###xml 679 687 670 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
###xml 824 827 815 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 844 852 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 I</xref>
###xml 905 908 896 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 951 954 942 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 980 988 971 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 I</xref>
###xml 1001 1009 992 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 J</xref>
###xml 1129 1137 1120 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 J</xref>
###xml 9 12 <span type="species:ncbi:10116">rat</span>
Neonatal rat ventricular cardiomyocytes (NRVCs) normally exit the cell cycle and enter G0 (Burton et al., 1999), but infection with a recombinant adenovirus encoding the N2ICD (Ad-N2ICD) dramatically changed the cell cycle profile of cardiomyocytes, increasing the percentage of NRVCs in S/G2/M phase 2.4-fold 48 h after infection (which corresponds to postnatal day 5 [P5]; Fig. 1, A, C, and D). In contrast, control NRVCs infected with an adenovirus encoding beta-galactosidase (Ad-betaGal) had no effect over background (Fig. 1, B and D). Ad-N2ICD also increased the incidence of Ki67+ NRVCs nearly 10-fold (Fig. 1, E, G, and H), whereas Ad-betaGal had no significant effect (Fig. 1 F). Notch signaling was confirmed by the induction of hairy and enhancer of split 1 (Hes1) promoter-dependent luciferase activity in Ad-N2ICD-infected cells (Fig. 1 I) and the expression of high levels of recombinant N2ICD (V5-tagged) protein in the nuclei of Ad-N2ICD-infected cardiomyocytes (Fig. 1 I, inset; and Fig. 1 J). Endogenous Notch2 in cardiomyocytes declined postnatally (not depicted) such that it was no longer detectable by P5 (Fig. 1 J), which indicates that exogenous reactivation of Notch2 can direct cell cycle entry.
###end p 12
###begin p 13
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activated Notch induces cell cycle reentry in quiescent cardiomyocytes.</bold>
###xml 163 166 160 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 309 310 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 396 397 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 443 444 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 733 734 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 756 757 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1001 1009 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla-</italic>
###xml 1158 1165 1149 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 1370 1371 1361 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1399 1400 1390 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1471 1474 1462 1465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1595 1596 1586 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
Activated Notch induces cell cycle reentry in quiescent cardiomyocytes. (A-D) NRVCs were either uninfected (A and E) or infected with Ad-betaGal (B and F) or Ad-N2ICD (C and G). 48 h after infection, cells were stained with mouse anti-MF20 (green, Alexa 488) and propidium iodide (PI; A-C). The number of MF20+ cells (green, Alexa 488) was >90% in all cases. DNA content was analyzed for the MF20+ population (insets) and the percentage in S/G2/M phase for each condition was calculated (D). The examples shown are representative of more than five experiments with similar outcomes. (E-H) Examples of NRVCs as in A-D stained with MF20 (red, Alexa 594) and Ki67 (green, Alexa 488; E-G) 48 h after infection, and the percentage of Ki67+ cells within the MF20+ population was measured (H). The examples shown are representative of more than five experiments with similar outcomes. (I) 12 h after infection, NRVCs were transfected with 0.6 mug of the pHes1-Luc or pDeltaHes1-Luc plasmids and 0.2 mug pGL3-Renilla-Luc. Luciferase activities and protein expression of Notch2 and V5 epitope (inset) were determined 12 h later. Firefly activity was normalized using Renilla luciferase activity. (J) Examples of NRVCs as in A-D stained with V5 (red, Alexa 594), Notch2, (green, Alexa 488), and DAPI (blue) 48 h after infection. (K) Confocal images showing the persistence of Ki67+ (green, Alexa 488) and MF20+ (red, Alexa 594) cardiomyocytes in differentiating mESCs expressing N2ICD from the MLC2V promoter compared with typically quiescent cardiomyocytes in cultures harboring only the REX promoter-Blar gene. Error bars indicate +/-SD across experimental replicates. Bars: (E-G and K) 10 mum; and (J) 50 mum.
###end p 13
###begin p 14
###xml 79 82 79 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 258 261 258 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 411 419 411 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 K</xref>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
Similarly, mESC lines were created with a dual-cassette vector that produced N2ICD under control of the ventricular cardiomyocyte-specific myosin light chain 2V (MLC2V) promoter and the blastocidinr gene for drug selection from the stem cell promoter Rex. N2ICD showed extended replicative capacity of cardiomyocytes to at least day 21 after initiation of differentiation, yielding overgrowths in the cultures (Fig. 1 K), whereas control mESCs harboring only Rex-Blar showed the normal cessation of cell division by day 12-16.
###end p 14
###begin title 15
###xml 6 9 6 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Notch2ICD induces expression and nuclear translocation of cyclin D1
###end title 15
###begin p 16
###xml 79 88 75 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Flox/Flox</sup>
###xml 231 252 219 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Tanigaki et al., 2002</xref>
###xml 326 329 314 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 407 413 391 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Neonatal mouse ventricular cardiomyocytes (NMVCs) were prepared from RBP-JkappaFlox/Flox mice to probe whether cell cycle reentry required RBP-Jkappa. Excision of exons 6 and 7 of RBP-Jkappa by Cre recombinase eliminates function (Tanigaki et al., 2002), and introduction of a Cre-EGFP fusion protein blocked the ability of N2ICD to stimulate cell cycle reentry, demonstrating the dependence on RBP-Jkappa (Fig. 2).
###end p 16
###begin p 17
###xml 0 39 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cell cycle reentry requires RBP-J&#954;.</bold>
###xml 66 75 58 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Flox/Flox</sup>
###xml 167 170 155 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 315 316 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 363 364 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 385 386 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 438 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 501 504 488 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 539 542 526 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Cell cycle reentry requires RBP-Jkappa. (A) Examples of RBP-JkappaFlox/Flox NMVCs infected with Ad-Cre-EGFP to remove RBP-Jkappa, then reinfected 12 h later with Ad-N2ICD, as indicated, cultured 48 h, and stained with MF20 (red, Alexa 594), Ki67 (far red, Cy5, shown as green), and DAPI (blue). Arrows indicate Ki67+ cells. Bar, 10 mum. (B) The percentage of Ki67+ cardiomyocytes (MF20+) in each condition. Only Cre-expressing cells (GFP+, green) were counted in cultures infected with Ad-Cre-EGFP. N2ICD induced KI67 (P = 0.05) but the N2ICD effect following Cre was not significantly different from that of Cre alone (ns). Error bars indicate +/-SD across experimental replicates.
###end p 17
###begin p 18
###xml 249 264 245 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">DeGregori, 2004</xref>
###xml 364 367 348 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 379 387 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 437 445 421 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 513 514 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 598 624 570 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Solodushko and Fouty, 2007</xref>
###xml 651 652 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 698 706 670 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 764 772 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 534 537 <span type="species:ncbi:10116">rat</span>
A potential transcriptional target of RBP-Jkappa is cyclin D1. Cyclin D1 and other D-type cyclins (D2 and D3) translocate to the nucleus, where they function with Cdk4 and 6 to phosphorylate Rb and cause progression through the cell division cycle (DeGregori, 2004). A time-dependant up-regulation of cyclin D1 was apparent beginning approximately6-9 h after Ad-N2ICD infection (Fig. 3 B). Cyclin D1 induction precedes cell cycle entry (Fig. 3 A) by approximately24 h, which correlates well with the duration of G1 phase observed for rat cells (i.e., 24 h in primary cultures of endothelial cells; Solodushko and Fouty, 2007). Also, the level of the G1/S-phase cyclin, cyclin E, increased at 36 h (Fig. 3 C), which correlates with the observed cell cycle profile (Fig. 3 A) and confirms the S-phase entry of NRVCs.
###end p 18
###begin p 19
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notch induces expression and nuclear localization of cyclin D1 and phosphorylation of Rb before cell cycle reentry.</bold>
###xml 191 197 191 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 326 329 326 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 370 373 370 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 464 467 464 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 575 578 575 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 756 759 753 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 951 954 948 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1095 1098 1091 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1289 1290 1285 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1316 1319 1312 1315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1584 1587 1578 1581 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Notch induces expression and nuclear localization of cyclin D1 and phosphorylation of Rb before cell cycle reentry. (A) The DNA content of the cardiac cells analyzed by flow cytometry (as in Fig. 1) at the indicated times after infection. One of two experiments with similar outcomes is shown. (B) Cyclin D1 and V5 epitope (N2ICD) expression in NRVCs infected with Ad-N2ICD at the indicated times after infection. (C) Time course of cyclin E expression after Ad-N2ICD infection of NRVCs. (D) Examples of nuclear localization of cyclin D1 (arrows) in NRVCs infected with Ad-N2ICD as compared with Ad-betaGal-infected control cultures 48 h after infection. Immunostaining is shown for cyclin D1 (green, Alexa 488), MF20 (red, Alexa 594), V5 epitope tag on N2ICD (far red, Cy5, shown as green), and DAPI (blue). Confocal microscopic images (insets) confirmed nuclear localization. (E) Phosphorylation status of Rb in NRVCs 30 h after infection with Ad-N2ICD or 24 h after treatment with 10% FCS or 20 muM PHE. 5 mM EDTA in the lysis buffer prevents phosphorylation from occurring in the lysates. N2ICD (V5 epitope), cyclin D1, phospho-Rb (Ser807/811, Ser795, and Ser780), Cdk4, Cdk6, and phospho-Cdc6 expression are shown. (F) Incidence of phospho-Rb (Ser807/811) in NRVC cardiomyocytes (MF20+ cells). Note that only N2ICD induced significant levels of phospho-Rb. Error bars indicate +/-SD. (G) Immunostaining with MF20 (red, Alexa 594) and for phospho-Rb (Ser807/811; green, Alexa 488) or cyclin D1 (green, Alexa 488). Note that cyclin D1 and phospho-Rb are present in the nuclei of N2ICD-expressing cells (arrow) but not in the nuclei of cells cultured with high serum or PHE. Higher-magnification images are shown in insets with DAPI staining (blue). Bars: (D) 10 mum; (G, top) 50 mum; (G, bottom) 10 mum.
###end p 19
###begin p 20
###xml 139 142 139 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Although low serum was included in the preceding experiments to enhance cell survival, its absence did not prevent cell cycle reentry by N2ICD (18.3% S+G2+M phase cells in uninfected cells vs. 44.4% in infected cells), which indicates that Notch-induced cell cycle reentry is independent of serum factors, consistent with induction of cyclin D1 by RBP-Jkappa. Moreover, even high (10%) serum was insufficient to stimulate cell cycle entry, see the following paragraph.
###end p 20
###begin p 21
###xml 57 60 57 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 145 148 145 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 242 250 239 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 440 448 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 518 533 515 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and G</xref>
###xml 602 610 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 638 641 635 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 713 724 710 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E&#8211;G</xref>
###xml 928 936 925 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 1207 1210 1204 1207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Cyclin D1 levels were elevated within the nuclei of Ad-N2ICD-infected NRVCs, visualized by coimmunofluorescent staining with the V5 epitope on N2ICD, but were absent in nuclei of control Ad-betaGal-infected NRVCs (arrows indicate examples in Fig. 3 D). Nuclear localization of cyclin D1 was accompanied by phosphorylation of Rb at Ser807/811, Ser795, and Ser 780 in extracts prepared with 10 mM EDTA to inhibit kinase activity after lysis (Fig. 3 E, right). Although phenylephrine (PHE) and 10% FCS induced cyclin D1 (Fig. 3, E and G), both failed to stimulate its characteristic nuclear localization (Fig. 3 G, inset, arrowhead in the N2ICD panel indicates a characteristic nuclear pattern), Rb phosphorylation (Fig. 3, E-G) or DNA synthesis (Fig. S1, available at ). Lysates prepared in the absence of EDTA to preserve kinase activity after dissolution of the cell membranes showed that PHE or FCS can stimulate Cdk activity (Fig. 3 E, left). Because Rb phosphorylation occurred under these conditions but not in the presence of EDTA, we concluded that PHE and FCS alone cannot stimulate Rb phosphorylation because the components are not colocalized in the nucleus. This raises the possibility that the N2ICD might have a unique role in localizing the cyclin D1-Cdk complex to the nucleus.
###end p 21
###begin title 22
Cyclin D1 nuclear localization requires notch ICD
###end title 22
###begin p 23
###xml 360 368 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 488 491 472 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 493 504 477 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A&#8211;C</xref>
###xml 547 555 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 775 783 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 811 819 787 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 892 900 868 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 1032 1035 1004 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
To distinguish induction of cyclin D1 gene expression from nuclear localization, we transfected NRVCs to express a constitutively active form of RBP-Jkappa made by fusion to the VP16 transactivation domain and a MYC epitope tag (pRBP-Jkappa-VP16). RBP-Jkappa-VP16 activates transcription of Notch-dependent genes, including pHes1-luciferase in cardiomyocytes (Fig. 4 F). RBP-Jkappa-VP16 induced the accumulation of cyclin D1 in the cytosol but not in the nucleus, as had been seen with N2ICD (Fig. 4, A-C), and did not stimulate cell cycle entry (Fig. 4 E), which confirms that elevated cyclin D1 expression is insufficient to promote cell cycle entry. As a control, a DNA-binding mutant (DBM) control of RBP-Jkappa (pRBP-Jkappa-DBM) that does not activate pHes1-luciferase (Fig. 3 F) did not induce cyclin D1 (Fig. 4 D). PHE or 10% FCS also induced only cytosolic accumulation of cyclin D1 (Fig. 3 G). The failure of activated RBP-Jkappa, PHE, or 10% FCS to localize cyclin D1 to the nucleus indicated a specific requirement for N2ICD.
###end p 23
###begin p 24
###xml 0 72 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RBP-J&#954; is insufficient to promote nuclear localization of cyclin D1.</bold>
###xml 272 275 259 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 465 466 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 483 484 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 935 936 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 941 942 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 966 967 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 972 973 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1018 1019 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1069 1070 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1121 1124 1086 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1135 1136 1100 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1209 1212 1170 1173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
RBP-Jkappa is insufficient to promote nuclear localization of cyclin D1. (A and B) Examples of NRVCs were transfected with 0.8 mug of plasmids encoding a myc epitope-tagged, constitutively active version of RBP-Jkappa in pCDNA3 (pRBP-Jkappa-VP16; A) or infected with Ad-N2ICD (B) and stained 48 h later for cyclin D1 (green, Alexa 488), c-myc epitope (red, Alexa 594), MF20 (red, Alexa 594), and DAPI (blue). Note the absence of nuclear localized cyclin D1 in c-myc+ (RBP-Jkappa-VP16+) cells. Circles indicate nuclear regions and arrows indicate nuclear localized cyclin D1. (C) Percentage of cardiomyocytes treated as in A and B showing nuclear versus cytosolic localization of cyclin D1. Error bars indicate +/-SD. (D) NRVCs transfected to express a control DNA-binding mutant of RBP-Jkappa (pRBP-Jkappa-DBM) and stained as in A. Only a basal level of cyclin D1 was detected. Circles indicate nuclear regions. (E) Percentage of c-myc+/Ki67+ (transfected) and c-myc-/Ki67+ (untransfected) cells for pRBP-Jkappa-VP16 (n = 69 and 107, respectively) and pRBP-Jkappa-DBM (n = 57 and 106, respectively) as compared with Ad-N2ICD infected (n = 100); results are representative of four trials. (F) RBP-Jkappa and N2ICD (0.5 mug of plasmid per transfection), as in A-E, showed expected activities on the pHes1-luciferase reporter (0.25 mug of plasmid per transfection); results are representative of two trials. Bars, 5 mum.
###end p 24
###begin p 25
###xml 2 5 2 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 69 78 65 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Flox/Flox</sup>
###xml 105 111 101 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 174 189 166 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A and E</xref>
###xml 204 210 196 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 214 217 206 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 353 361 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 470 478 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 499 507 484 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 569 584 554 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, C and D</xref>
###xml 636 644 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 675 676 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 680 683 665 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 683 684 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 817 820 802 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 983 986 968 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 988 996 973 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
N2ICD also stimulated nuclear localization of cyclin D1 in RBP-JkappaFlox/Flox NMVCs after Cre excision (Fig. 5). Ad-Cre-EGFP on P1 effectively excised RBP-Jkappa 1 d later (Fig. 5, A and E). As shown in Fig. 2, N2ICD cannot induce cyclin D1 in the absence of RBP-Jkappa, therefore 10% FCS was added 1 d before harvesting the cells to induce cyclin D1 (Fig. 5 A). Ad-betagal-treated cells showed the characteristic cytoplasmic and perinuclear localization of cyclin D1 (Fig. 5 B), whereas Ad-N2ICD (Fig. 5 B) and the sequential treatment with Ad-Cre-EGFP and Ad-N2ICD (Fig. 5, C and D) both induced nuclear localization. Closed arrows (Fig. 5 D) indicate examples of Cre-EGFP+, N2ICD+ cells with nuclear localization of cyclin D1. Prominent nuclear expression of cyclin D1 was seen in the rare cells that expressed N2ICD but had not received Cre-EGFP (indicated by open arrows). In contrast, cyclin D1 was cytoplasmic and perinuclear in cells that had Cre-EGFP but did not express N2ICD (Fig. 5 D, indicated by asterisks). Collectively, RBP-Jkappa is required for Notch to induce cyclin D1 transcription but not for nuclear localization.
###end p 25
###begin p 26
###xml 0 60 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nuclear localization of cyclin D1 is RBP-J&#954; independent.</bold>
###xml 100 109 92 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Flox/Flox</sup>
###xml 588 591 576 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 785 786 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 790 793 778 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 793 794 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 894 897 882 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1042 1045 1030 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Nuclear localization of cyclin D1 is RBP-Jkappa independent. (A) NMVCs were isolated from RBP-JkappaFlox/Flox pups on the day of birth (P1) and treated as indicated until processing for immunostaining (the equivalent of P6). 10% FCS was added to induce cyclin D1 in the absence of RBP-Jk. (B-D) Confocal images of NMVCs showing nuclear localization of cyclin D1 (green, Alexa 568; "a" and "b" panels) overlapping with DAPI (blue; "a" panels). alpha-actinin cytosolic immunostaining identified cardiomyocytes, and nuclear V5 epitope immunostaining identified cells expressing transduced N2ICD (both visualized with a far red [Alexa 680] secondary antibody and shown as red in "c" panels). EGFP (D, d) shows Cre-EGFP fusion protein expression. Closed arrows indicate examples of Cre-EGFP+, N2ICD+ cells with nuclear localization of cyclin D1. Open arrows indicate the rare cells that expressed N2ICD but did not express Cre-EGFP; note the prominent nuclear presence of cyclin D1. The asterisks indicate a cell that expressed Cre-EGFP but not N2ICD; note that cyclin D1 was cytoplasmic and perinuclear. (E) RBP-Jkappa protein expression 1 and 3 d after Ad-Cre-EGFP treatment (corresponding to P3 and P5), showing efficient depletion by Cre.
###end p 26
###begin title 27
Notch-regulated nuclear export versus import of cyclin D1
###end title 27
###begin p 28
###xml 275 278 269 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 358 376 352 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Diehl et al., 1998</xref>
Nuclear localization of cyclin D1 is controlled by a fine balance between import, through an unknown mechanism, and export through the chromosome region maintenance 1 (CRM1)/exportin-1 transporter. Cyclin D1 phosphorylation by glycogen synthase kinase-3beta (GSK3beta) at Thr286 is thought to trigger export to the cytosol and degradation by the proteasome (Diehl et al., 1998).
###end p 28
###begin p 29
###xml 13 16 13 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 249 252 246 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 254 262 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 290 308 287 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Tseng et al., 2006</xref>
###xml 463 474 460 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B&#8211;D</xref>
###xml 511 522 508 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, E&#8211;G</xref>
To test if N2ICD regulates export, we first compared its action to 6-bromoindirubin-3'-oxime (BIO), a small molecule inhibitor of GSK3beta. BIO induced cell cycle reentry in a dose-dependent manner, albeit less dramatically than what is seen with N2ICD (Fig. 6 A), as previously described (Tseng et al., 2006). The inactive control compound MetBIO failed to promote cell cycle reentry of NRVCs. BIO, but not MetBIO, also caused nuclear accumulation of cyclin D1 (Fig. 6, B-D) and phosphorylation of nuclear Rb (Fig. 6, E-G), which is suggestive that retention of cyclin D1 in the nucleus contributes to cell cycle entry by BIO.
###end p 29
###begin p 30
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notch-induced nuclear accumulation of cyclin D1 in NRVCs is not caused by inhibition of export.</bold>
###xml 255 256 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 295 301 292 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 695 698 692 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 822 830 817 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla-</italic>
###xml 1007 1014 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 1038 1041 1030 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1167 1170 1154 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 1209 1212 1196 1199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1256 1259 1242 1245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1279 1282 1265 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 1388 1391 1374 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1498 1501 1484 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Notch-induced nuclear accumulation of cyclin D1 in NRVCs is not caused by inhibition of export. (A) NRVCs were treated for 36 h with the GSK3beta inhibitor BIO or control MetBIO before staining with MF20 and analysis of DNA content of cardiomyocytes (MF20+ population) by flow cytometry, as for Fig. 1. One of two experiments with identical outcomes is shown. (B-G) NRVCs were treated for 24 h with the indicated concentrations of BIO (B, C, E, and F) or MetBIO (D and G) before staining with MF20 (red, Alexa 594) and for cyclin D1 (green, Alexa 488; B-D) or phospho-Rb (Ser807/811; green, Alexa 488; E-G). BIO induced both nuclear accumulation of cyclin D1 and phosphorylation of Rb. (H) Ad-N2ICD-infected or control NRVCs were transfected with 0.6 mug pTopFlash-tk-Luc or pGL3-tk-Luc, as indicated, and 0.2 mug of pGL3-Renilla-Luc before exposure with BIO (0.25 muM, 0.5 muM, or 1 muM) for an additional 36 h before luciferase activities were determined. Firefly luciferase activity was normalized using Renilla luciferase activity. N2ICD did not modulate the beta-catenin/T cell factor-dependent transcription. Error bars indicate +/-SD. (I) Total and phospho-Thr286-cyclin D1 in NRVCs infected with Ad-N2ICD or treated with 10% FCS or PHE (20 muM). N2ICD did not prevent Thr286 phosphorylation of cyclin D1. (J) LMB enhanced nuclear localization of cyclin D1 (green, Alexa 488) by N2ICD (red, Alexa 594; arrows) but did not act on uninfected cells (circled nuclei), which is consistent with N2ICD regulating nuclear localization upstream of export by the CRM1-exportin-1 complex. Bars: (B-D) 10 mum; (E-G) 25 mum; (J) 10 mum.
###end p 30
###begin p 31
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 254 262 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 H</xref>
###xml 300 303 291 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 348 352 339 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD&#8211;</sub>
###xml 526 534 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 I</xref>
###xml 564 567 555 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
Unlike BIO, N2ICD did not inhibit GSK3beta, which was determined by monitoring luciferase activity from the T cell factor-dependent luciferase activity from the pTOPflash reporter plasmid that senses stabilized beta-catenin, a direct target of GSK3beta (Fig. 6 H). Moreover, the levels of phospho-Thr286-cyclin D1 levels were not inhibited in Ad-N2ICD-infected NRVCs but were in fact up-regulated compared with controls and, more importantly, with PHE- or 10% FCS-treated NRVCs, which also expressed high levels of Cyclin D1 (Fig. 6 I). The increase in phospho-Thr286-cyclin D1 correlated with increased levels of nuclear cyclin D1 available for phosphorylation by GSK3beta.
###end p 31
###begin p 32
###xml 202 205 202 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 213 221 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 J</xref>
###xml 301 304 301 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 353 356 353 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 356 357 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 J</xref>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 J</xref>
###xml 498 501 498 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 574 575 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 685 705 685 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">Yoshida et al., 1990</xref>
###xml 782 785 782 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 850 853 847 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
As an independent test for regulated export, cells were treated with leptomycin B (LMB) to specifically inhibit CRM1/exportin-1. LMB enhanced nuclear localization of cyclin D1 beyond that achieved by N2ICD alone (Fig. 6 J). Furthermore, LMB stimulated nuclear cyclin D1 only in cells that expressed N2ICD and not in control, uninfected cells (compare N2ICD+ cells [Fig. 6 J, indicated by arrows] to uninfected cells [Fig. 6 J, indicated by circles]). These data are consistent with the idea that N2ICD acts upstream of CRM1/exportin-1. LMB did not increase the number of S/G2/M cells (unpublished data) because inhibition of CRM1/exportin-1 inhibition prevents cell cycle progression (Yoshida et al., 1990). The results with LMB, together with the lack of an inhibitory effect of N2ICD on GSK3beta or the phosphorylation of cyclin D1, suggest that N2ICD does not control export or degradation but might stimulate nuclear import.
###end p 32
###begin title 33
Activation of the DNA damage checkpoint in older NRVCs
###end title 33
###begin p 34
###xml 123 125 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 144 146 144 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 160 163 160 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 366 384 366 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Adams et al., 2001</xref>
###xml 386 405 386 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Crosio et al., 2002</xref>
###xml 503 505 503 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 513 528 513 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, H and I</xref>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 695 698 695 698 <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="article-reference" vol="183" page="117" id="N0x1f87a90N0x417b250" xlink:href="18824567" ext-link-type="pubmed">117</related-article>
Activated Notch effectively stimulated P2 NRVCs to enter mitosis, as revealed by phosphorylation of histone 3 (His3) on Ser10 (62.1% phospho-Ser10-His3+ in AdN2ICD-infected P2 NRVCs vs. 44.5% for uninfected; P < 0.001, two-tailed Student's t test). The presence of phospho-Ser10 is a hallmark for entry into mitosis and is required for chromatin condensation (e.g., Adams et al., 2001; Crosio et al., 2002). In striking contrast, older P5 NRVCs completely failed to phosphorylate His3 (0.57% phospho-Ser10-His3+; Fig. 7, H and I), which revealed a postnatal decline in the ability to traverse the G2/M interphase. A similar postnatal decline in cell division was noted by Collesi et al. (see p. 117 of this issue) in response to stimulation by exogenous Jagged.
###end p 34
###begin p 35
###xml 5 8 5 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ad-N2<sub>ICD</sub>&#8211;infected NRVCs arrest at the G<sub>2</sub>/M interphase.</bold>
###xml 112 115 112 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 378 379 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 395 396 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 426 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 545 546 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 567 570 564 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 836 839 830 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1051 1052 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1166 1169 1160 1163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Ad-N2ICD-infected NRVCs arrest at the G2/M interphase. (A and B) 3 d after birth, NRVCs were infected with Ad-N2ICD or Ad-beta-gal, or not infected, and, 12 h later, treated with aphidicolin or nocodazole for an additional 36, 48, or 60 h. For nocodazole+ release, nocodazole was removed during the last 12 h of culture (see schematic in A, top). The percentages of cells in S/G2/M phase in MF20+ (cardiomyocytes; A) and MF20- (noncardiomyocytes; B) populations were determined from flow cytometry. Nocodazole did not increase the incidence of G2/M cells among the N2ICD-treated cardiomyocyte population, which is indicative of a block at the onset of M phase. The example shown is representative of four experiments with similar outcomes. (C-I) NRVCs were either left uninfected (C and F) or infected with Ad-betaGal (D and G) or Ad-N2ICD (E and H), cultured for 48 h, then stained with MF20 (red, Alexa 594) and for AuroraB (green, Alexa 488; C-E) or for phospho-His3 (Ser10; green, Alexa 488; F-H). The percentages of positive cells within the MF20+ population was then determined (I). Nuclear-localized AuroraB but not phospho-His3 was detected in response to N2ICD. Error bars indicate +/-SD. Bar, 25 mum.
###end p 35
###begin p 36
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 331 332 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 378 381 378 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 428 429 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 462 470 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 579 580 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 672 673 672 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 683 691 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 1034 1035 1034 1035 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1088 1089 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1130 1131 1130 1131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1194 1202 1194 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
To understand the nature of the block, we probed the cell cycle status of treated cells using the DNA polymerase inhibitor aphidicolin or the mitotic spindle assembly inhibitor nocodazole for various times to block the cell cycle (see Fig. 7 A, inset, for experimental design). As expected, aphidicolin, which blocks cells at the G1/S interphase, reduced the percentage of Ad-N2ICD-expressing NRVCs that had progressed into S, G2, or M phases of the cell cycle (Fig. 7 A), confirming entry into S phase. Nocodazole interferes with microtubules and causes cells to arrest at the G2/M interphase. Importantly, nocodazole did not alter the percentage of cardiomyocytes in S/G2/M phase (Fig. 7 A), which is suggestive of the fact that cells were already arrested at this point. To test this idea, the nocodazole was washed out during the last 12 h of culture. Normally, cycling cells resume progression after removal of nocodazole; however, this had no effect on the P5 NRVCs, which indicates that they were likely arrested at or before G2/M. In contrast, the residual noncardiomyocytes (MF20- cells) in the preparations arrested at G2/M upon nocodazole treatment and were released by its removal (Fig. 7 B), which demonstrates that the Notch-induced block was specific to the cardiomyocytes in the cell preparation.
###end p 36
###begin p 37
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 59 71 59 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 (C&#8211;I)</xref>
###xml 78 81 78 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 190 192 190 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 311 312 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
AuroraB directly phosphorylates Ser10 of His3. As shown in Fig. 7 (C-I), Ad-N2ICD dramatically increased AuroraB expression in the nuclei of P5 NRVCs but completely failed to induce His3 Ser10 phosphorylation in control uninfected or Ad-betaGal-infected NRVCs. A blockade at the level of AuroraB confirmed the G2/M arrest and suggested activation of the DNA damage checkpoint.
###end p 37
###begin p 38
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 271 290 271 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Kastan et al., 1991</xref>
###xml 292 313 292 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Sarkaria et al., 1999</xref>
###xml 479 481 479 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 548 559 548 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, A&#8211;E</xref>
###xml 577 580 577 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 807 822 807 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, I and J</xref>
###xml 958 969 958 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Belka, 2006</xref>
###xml 1120 1122 1120 1122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">15</sub>
###xml 1167 1175 1167 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 K</xref>
###xml 1208 1210 1208 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">15</sub>
###xml 1221 1224 1221 1224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1383 1386 1383 1386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1431 1433 1431 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">15</sub>
###xml 1494 1497 1494 1497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1593 1594 1593 1594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Caffeine effectively overrides DNA damage G2/M checkpoint activation and can permit entry of arrested cells into M phase by inhibiting the ataxia telangiectasia mutated (ATM) and ATM and Rad-3 related (ATR) kinases, and most likely other DNA checkpoint components (e.g., Kastan et al., 1991; Sarkaria et al., 1999). Entry into M phase in the presence of caffeine is therefore diagnostic of checkpoint activation. Caffeine treatment alone did not increase the level of phospho-Ser10-His3 in uninfected P5 NRVCs and in fact caused a minor reduction (Fig. 8, A-E). In contrast, N2ICD increased the number of phospho-His3+ NRVCs by 3.5-fold. Overriding checkpoint activation pushed cells into mitosis and resulted in cell death, visualized by an 87-fold increase in the number of TUNEL-positive cardiomyocytes (Fig. 8, I and J), which is consistent with induction of programmed cell death when the checkpoint is overridden in cells with DNA replication defects (Belka, 2006). The mitosis-inducing kinase Cdc2 is a key component of the DNA damage checkpoint pathway downstream of ATM/ATR and Chk1, and it shows inhibitory Tyr15 phosphorylation with checkpoint activation. Fig. 8 K shows an increase in phospho-Tyr15-Cdc2 in N2ICD-stimulated NRVCs, as well as a possible increase in the total Cdc2 protein levels, providing further evidence of DNA damage checkpoint activation after the N2ICD-induced cell cycle. As expected, phospho-Tyr15-Cdc2 returned to basal levels after caffeine treatment of N2ICD-stimulated P5 cardiomyocytes. We conclude that activation of DNA damage checkpoint causes the G2/M arrest and is triggered as a consequence of improper or incomplete DNA synthesis during S phase.
###end p 38
###begin p 39
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA damage checkpoint activation implicated in G<sub>2</sub>/M arrest.</bold>
###xml 103 106 103 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 417 418 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 670 673 670 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 862 865 862 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 943 946 943 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
DNA damage checkpoint activation implicated in G2/M arrest. (A-E) NRVCs were either infected with Ad-N2ICD or left uninfected. 24 h later, 10 mM caffeine (C, D, H, and I) or control (A, B, F, and G) media were added. Cells were then cultured for an additional 24 h, by which time they were at P5, and stained with MF20 (red, Alexa 594) and for phospho-His3 (Ser10; green, Alexa488; A-D). The incidence of phospho-His3+, MF20+cardiomyocytes is shown (E). (F-J) Alternatively, a TUNEL assay (green, fluorescein) was performed before immunostaining with MF20 (red, Alexa594). Note that caffeine permitted the induction of phospho-His3 but triggered TUNEL reactivity. (K) N2ICD (anti-V5 epitope) and cyclin D1 expression, and the corresponding levels of phosphorylated Cdc2 are shown for NRVCs prepared as in A-E. Elevated phospho-Cdc2 was observed with activated N2ICD and reduced by caffeine to basal levels, which together is indicative that N2ICD treatment activates the DNA damage checkpoint. alpha-actinin and nonspecific proteins are shown as loading controls. Error bars indicate +/-SD. Bars, 25 mum.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 406 412 402 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
We found that cell cycle entry of mESC-derived and quiescent cardiomyocytes could be profoundly enhanced by Notch activation, which controlled expression and nuclear localization of cyclin D1. Transcriptional induction of the cyclin D1 gene required canonical Notch signaling through RBP-Jkappa. Nuclear localization however was a distinct property of the Notch ICD that is essential for cell cycle entry (Fig. 9). The implications of these findings for regulating expansion of cardiomyogenic progenitor or precursor cells and in the control of other normal and pathological processes, such as tumorigenesis, are discussed in the following paragraphs.
###end p 41
###begin p 42
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of Notch2-induced cell cycle entry.</bold>
Summary of Notch2-induced cell cycle entry. RBP-Jkappa-dependent transcription leads to accumulation of cyclin D1 in the cytosol. Notch ICD regulates entry into the cell cycle by controlling nuclear localization of cyclin D1 independently of RBP-Jkappa.
###end p 42
###begin title 43
Notch and cardiomyocyte cell cycle reentry
###end title 43
###begin p 44
###xml 213 242 205 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Ronchini and Capobianco, 2001</xref>
###xml 557 586 545 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Tamamori-Adachi et al. (2003)</xref>
Our finding that RBP-Jkappa-dependent Notch signaling induced expression of cyclin D1 in quiescent cardiomyocytes is consistent with the presence of a functional RBP-Jkappa-binding site in the cyclin D1 promoter (Ronchini and Capobianco, 2001). FCS and PHE also induced cyclin D1 and, like activated RBP-Jkappa, were insufficient to promote nuclear translocation and cell cycle reentry. Nuclear localization of cyclin D1 by Notch ICD coupled with the developmental decline in endogenous Notch during early postnatal development could explain the results of Tamamori-Adachi et al. (2003), who showed that although ectopically expressed cyclin D1 accumulates in the nucleus of still-proliferating fetal cardiomyocytes, it is sequestered in the cytoplasm of normally quiescent NRVCs. Moreover, fusion to a nuclear localization sequence that targeted cyclin D1 to the nucleus was sufficient to induce Rb phosphorylation and cell cycle reentry of quiescent NRVCs.
###end p 44
###begin p 45
###xml 171 174 171 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 272 290 272 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Diehl et al., 1998</xref>
###xml 331 334 331 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 430 433 430 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 498 501 498 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 535 538 535 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 610 613 607 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
###xml 703 706 700 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 785 788 782 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 888 906 885 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Tseng et al., 2006</xref>
###xml 956 959 953 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink">286</sub>
The localization of cyclin D1 to the nucleus probably occurs as a balance between import, for which the mechanism is poorly understood, and regulated export of phospho-Thr286-cyclin D1 through the transporter CRM1 into the cytosol, where it is degraded by the proteosome (Diehl et al., 1998). Two lines of evidence indicate that N2ICD acts upstream of export: first, we noted a superaccumulation of cyclin D1 in the presence of N2ICD and LMB, which inhibits CRM1-mediated export, indicating that N2ICD acts upstream of CRM1. Second, N2ICD did not modulate GSK3beta activity nor reduce the levels of phospho-Thr286-cyclin D1, as did BIO. Thus, inhibition of export seems unlikely to be responsible for N2ICD-directed nuclear accumulation of cyclin D1, and we favor the model in which N2ICD regulates import. In contrast, BIO itself is sufficient to promote cardiomyocyte cell cycle entry (Tseng et al., 2006), and we propose that inhibition of cyclin D1 Thr286 phosphorylation, leading to protein stabilization and nuclear localization, is the likely mechanism.
###end p 45
###begin p 46
###xml 106 109 106 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 329 332 329 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 519 523 519 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WAF1</sup>
###xml 561 591 561 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Sumrejkanchanakij et al., 2003</xref>
###xml 895 916 895 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Miyamoto et al., 2003</xref>
###xml 918 937 918 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">van Es et al., 2005</xref>
###xml 939 961 939 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Stylianou et al., 2006</xref>
How might the Notch ICD promote nuclear translocation? We did not detect a physical interaction between N2ICD and cyclin D1, Cdk4, or Cdk6 by coimmunoprecipitation from NRVCs (unpublished data). Moreover, the spatially localized immunostaining pattern of cyclin D1 within the nucleus differed from the diffuse pattern seen for N2ICD or its V5 epitope tag; thus, Notch might not participate directly in a cyclin D complex. In terminally differentiated neurons, cyclin D1 becomes cytoplasmic, and forced expression of p21WAF1 (Cip1) induces nuclear accumulation (Sumrejkanchanakij et al., 2003), so one possibility is that Notch modulates the interaction of cyclin D1 with proteins such as p21. Little is known about the mechanism that keeps cyclin D1 from entering the nuclei of terminally differentiated cells, but activated Notch is seen in several tumors, such as breast, colon, and pancreas (Miyamoto et al., 2003; van Es et al., 2005; Stylianou et al., 2006), and it will be interesting to evaluate whether it controls cyclin D1 trafficking in cancers.
###end p 46
###begin title 47
Progression through the cell cycle: implications of the neonatal decline in mitotic response to Notch
###end title 47
###begin p 48
###xml 302 308 302 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
Between days 4 and 7 after birth, NRVCs lose most of their ability to respond to exogenous Notch, first because of the decline in Notch 1 and Notch 2 receptors (unpublished data; Collesi et al., 2008) but also because of a pronounced activation of DNA damage checkpoint in response to activated Notch (Fig. 8). As expected, overriding the checkpoint pushed the cardiomyocytes into mitosis, resulting in mitotic catastrophe and apoptosis.
###end p 48
###begin p 49
###xml 118 135 118 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Agah et al., 1997</xref>
###xml 137 153 137 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Huh et al., 2001</xref>
###xml 155 176 155 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Datwyler et al., 2003</xref>
###xml 178 206 178 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Tamamori-Adachi et al., 2003</xref>
###xml 208 226 208 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Engel et al., 2005</xref>
###xml 228 245 228 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Jung et al., 2005</xref>
###xml 247 265 247 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Tseng et al., 2006</xref>
Several studies have shown that manipulation of cell cycle proteins can induce NRVCs to reenter the cell cycle (e.g., Agah et al., 1997; Huh et al., 2001; Datwyler et al., 2003; Tamamori-Adachi et al., 2003; Engel et al., 2005; Jung et al., 2005; Tseng et al., 2006). These studies used reagents (e.g., BrdU incorporation or Ki67 immunostaining) that reflect entry into the cell cycle or S phase but not entry into mitosis or cell division. Based on our results that DNA damage checkpoint activation limits cell division of late-stage quiescent cardiomyocytes, it is important to quantitatively evaluate whether treatment with these or other reagents can indeed direct cells to enter mitosis and divide.
###end p 49
###begin p 50
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Checkpoint activation is not solely a consequence of Notch activation. The majority of BIO-treated P5 NRVCs also arrested at G2/M and showed DNA damage checkpoint activation, as demonstrated by caffeine sensitivity and Cdc2 phosphorylation (unpublished data). In the context of the adult heart, a beneficial function of DNA damage checkpoint activation might be to protect mature cardiomyocytes from apoptosis and cell death after exposure to stimuli that support replication of nonmyocytes during normal heart function or pathologically as a response to injury or remodeling.
###end p 50
###begin p 51
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 101 98 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 449 464 449 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Li et al., 1997</xref>
###xml 466 484 466 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Ahuja et al., 2004</xref>
###xml 562 563 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 569 570 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1019 1028 1019 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WAF1/Cip1</sup>
###xml 1036 1040 1036 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 1066 1075 1066 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WAF1/Cip1</sup>
###xml 1125 1126 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1135 1136 1135 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1207 1211 1207 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 1353 1356 1353 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Although most cardiomyocytes after P3-5 arrested at the G2/M interphase, a minor fraction of Ad-N2ICD-infected NRVCs could be found at all mitotic phases, including cytokinesis (Fig. S2, available at ); however, the incidence was the same as in uninfected NRVCs. The complex structure of sarcomeric apparatus has been proposed to block chromosomal segregation and cytokinesis should mature cardiomyocytes be stimulated to reenter in the cell cycle (Li et al., 1997; Ahuja et al., 2004). The normally striated staining of MF20 in nondividing cardiomyocytes (see G0 and G1 in Fig. S2 A) was diffuse in the dividing cells, and the distinction of whether dividing cells underwent some degree of disassembly or reflected a less mature subpopulation should be investigated. The dividing cardiomyocytes showed normal hallmarks of M phase. For instance, AuroraB was associated with chromosomes during anaphase and localized at the midbody during cytokinesis (Fig. S2, B and C), as expected for dividing cells. Regulation of p21WAF1/Cip1 and p57Kip2 also appeared normal. p21WAF1/Cip1 was expressed normally in the nuclei of both Ki67+ and Ki67- cells and disappeared during mitosis, and the normal expression of p57Kip2 also disappeared during mitosis (Fig. S2, D-F). Interestingly, once the nuclear membrane was disintegrated, staining for the V5 epitope on N2ICD became cytoplasmic, which indicates cytosolic relocalization of the protein (Fig. S2 G).
###end p 51
###begin title 52
Notch in ventricular development and disease
###end title 52
###begin p 53
###xml 427 446 427 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Loomes et al., 2002</xref>
###xml 448 470 448 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Rutenberg et al., 2006</xref>
###xml 472 496 472 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Grego-Bessa et al., 2007</xref>
###xml 498 522 498 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Niessen and Karsan, 2007</xref>
###xml 767 791 767 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Grego-Bessa et al., 2007</xref>
###xml 983 1001 983 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Kozar et al., 2004</xref>
###xml 1151 1152 1151 1152 <sub xmlns:xlink="http://www.w3.org/1999/xlink">k</sub>
###xml 891 896 <span type="species:ncbi:10090">mouse</span>
We evaluated Notch2 because it is the predominant isoform present on cardiomyocytes while the chamber myocardium is growing during mid-to-late gestation. An implication of our data is that Notch2 in the fetal heart might prevent differentiation and sustain replication of newly formed cardiomyocytes to permit the dramatic growth of ventricular myocardium, which expresses Jagged1, Jagged2, and Notch2 in overlapping patterns (Loomes et al., 2002; Rutenberg et al., 2006; Grego-Bessa et al., 2007; Niessen and Karsan, 2007). Although the phenotypes caused by systemic deletions of Notch signaling components are consistent with such a model, the cardiac defects are likely to also be caused by secondary consequences of the loss of Notch, such as in the endocardium (Grego-Bessa et al., 2007). All 3D-type cyclins are present in the developing heart, and, interestingly, the triple knockout mouse exhibited severely hypoplastic ventricular myocardium and died by embryonic day 16.5 (Kozar et al., 2004). Thus, we speculate that myocyte-autonomous Notch-cyclin D interactions might underlie ventricular growth. Myocardial conditional knockouts of RBP-Jk and Notch2 using appropriate Cre lines are being analyzed to address this issue.
###end p 53
###begin p 54
###xml 248 266 248 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Hsieh et al., 2007</xref>
###xml 395 412 395 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Raya et al., 2003</xref>
###xml 344 353 <span type="species:ncbi:7955">zebrafish</span>
###xml 419 428 <span type="species:ncbi:7955">zebrafish</span>
An important implication of this study is that Notch might play a similar role after myocardial injury by sustaining proliferation of a committed precursor or progenitor pool, although the origin and prevalence of such cells remains unclear (e.g., Hsieh et al., 2007) and a direct role for Notch remains to be tested. Regeneration of the adult zebrafish heart is preceded by Notch reactivation (Raya et al., 2003). The zebrafish Notch isoform characterized as being involved, Notch1b, is expressed by endothelial cells of the endocardium rather than by the myocardium, and, therefore, would be expected to influence cardiomyocyte regeneration only indirectly. Thus, whether Notch signaling exerts a cell-autonomous effect in regenerating cardiomyocytes needs to be resolved using appropriate transgenic models and development of specific agonists to stimulate such cells in situ.
###end p 54
###begin title 55
Materials and methods
###end title 55
###begin title 56
Cell culture
###end title 56
###begin p 57
###xml 162 163 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 596 597 584 585 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 696 697 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 706 707 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1247 1248 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r</sup>
###xml 1277 1280 1265 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 1306 1326 1294 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Barcova et al., 2007</xref>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 223 227 <span type="species:ncbi:10116">rats</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 660 665 <span type="species:ncbi:9796">horse</span>
###xml 1048 1053 <span type="species:ncbi:10090">mouse</span>
###xml 1205 1208 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Ventricular cardiomyocytes were isolated with a neonatal rat/mouse cardiomyocyte isolation kit (Cellutron) and cultured at 37degreesC in humidified air with 5% CO2. In brief, ventricles were dissected from 1-2-d-old Hsd:SD rats (Sprage Dawley) or mice, then digested five times for 15 min each with the enzyme cocktail at 37degreesC. Cells were pooled, preplated for 90 min on an uncoated dish to remove fibroblasts, and plated on 1% gelatin-coated cell culture plastic dishes in high-serum media (DME/F12 [1:1], 0.2% BSA, 3 mM sodium-pyruvate, 0.1 mM ascorbic acid, 4 mg/liter transferrin, 2 mM l-glutamine, and 5 mg/liter ciprofloxacin supplemented with 10% horse serum and 5% FCS) at 1.25 x 105 cells/cm2. After 24 h, media was changed to low-serum medium (same but with 0.25% FCS) and cultured until use. Nearly all cardiomyocytes were quiescent by P3. The purity of cultures was routinely determined by immunofluorescence staining with an anti-muscle myosins antibody (MF20; Developmental Biology Hybridoma Bank) and Alexa 594-conjugated anti-mouse immunoglobulin secondary antibodies (Invitrogen), and only preps with >90% of cardiomyocytes were used for analyses. CGR8 mESCs were created by stable HIV lentiviral transduction to express Blar from the Rex promoter and N2ICD from the MLC2V promoter (Barcova et al., 2007), and embryoid bodies were prepared by removal of leukemia inhibitory factor and aggregation in serum-containing medium.
###end p 57
###begin title 58
Adenoviral infection
###end title 58
###begin p 59
###xml 5 8 5 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 75 93 75 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Small et al., 2003</xref>
Ad-N2ICD (provided by T. Maciag, Maine Medical Institute, Scarborough, ME; Small et al., 2003), Ad-betaGal (Clontech Laboratories, Inc.), and Ad-Cre-EGFP (a gift from S.V. Kozlov, National Cancer Institute, National Institutes of Health, Bethesda, MD) are replication-deficient, serotype 5 adenoviruses. Viruses were propagated and concentrated using an Adenopure kit (Puresyn, Inc.), and viral titers were determined by using the Adeno-X Rapid Titer kit (Clontech Laboratories, Inc.). Cardiomyocytes were infected overnight in low-serum media at a multiplicity of infection of four to five viruses per cell. The media was replaced 12-14 h after infection with fresh low-serum media. Optimal titers for infection were determined empirically for each batch of virus based on cyclin D1 expression and cell cycle entry.
###end p 59
###begin title 60
Transfection and luciferase assay
###end title 60
###begin p 61
###xml 239 262 234 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Luckow and Schutz, 1987</xref>
###xml 383 405 362 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Rutenberg et al., 2006</xref>
###xml 820 826 795 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 832 850 <span type="species:ncbi:11886">Rous sarcoma virus</span>
Cardiomyocytes were transfected for 6-8 h in serum-free media with 0.8 mug of DNA using Lipofectamine 2000 (Invitrogen) with pHes1-Luc and pDeltaHes1-Luc (provided by J. Griffin, Dana-Farber Cancer Institute, Boston, MA); TOPFlash-tk-Luc (Luckow and Schutz, 1987) and pGL3-tk-Luc (Promega); pRS2-RBP-Jkappa-VP16, pRS2-RBP-Jkappa-DBM, pCDN3-RBP-Jkappa-VP16, and pCDN3-RBP-Jkappa-DBM (Rutenberg et al., 2006); and pRL-tk (Promega) to normalize for transfection efficiency. The media was replaced after transfection with fresh low-serum media and cultured for 36 h before staining or determination of luciferase activities using the Dual-Luciferase system (Promega). For the engineered RBP-Jkappa-VP16 and DBM variants, the results were similar whether the promoter used was cytomegalovirus, as used in adenovirus vectors (Fig. 4), or Rous sarcoma virus, which is more potent in cardiomyocytes.
###end p 61
###begin title 62
Immunofluorescence staining
###end title 62
###begin p 63
###xml 292 299 286 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 760 761 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 180 184 <span type="species:ncbi:9925">goat</span>
After cardiomyocytes were fixed in 4% PFA for 15 min at room temperature, nonspecific binding was blocked for at least 1 h with blocking buffer (PBS x 1, 50 mM glycine, 2% BSA, 2% goat serum, and 0.01% sodium-azide). Next, cells were incubated overnight at 4degreesC with primary antibodies (Table I) in washing buffer (blocking buffer diluted 1:10 in PBS x 1), and immune complexes were detected with Alexa 488, Alexa 594 (Invitrogen), and Cy5-conjugated (Jackson ImmunoResearch Laboratories) secondary antibodies diluted 1:250 in washing buffer and counterstained with 0.5 mug/ml DAPI. TUNEL staining was performed with the in situ Cell Death Detection kit (Roche). Statistical significance was indicated by p-value as calculated from a two-tailed Student's t test.
###end p 63
###begin title 64
Antibodies and dilutions used for immunofluorescent detection of proteins
###end title 64
###begin p 65
After immunostaining, the cultures were mounted in Dako medium (Dako), and wide-field images were acquired at room temperature on an inverted fluorescence microscope (SX71; Olympus) with a 20x 0.40 NA or 40x 0.60 NA objective (Olympus) using a camera (C47425; Hamamatsu) and MetaMorph version 6 acquisition software (MDS Analytical Technologies). For high-magnification and confocal images, cells were plated on 1% gelatine-coated chamber slides (Permanox; Nunc). Wide-field images were acquired at room temperature on a microscope (Axioplan; Carl Zeiss, Inc.) with a 40x 0.74 NA or 63x 1.4 NA objective (Carl Zeiss, Inc.) using a Spot RT camera (Diagnostic Instruments, Inc.) and MetaMorph version 6 acquisition software. Confocal images were acquired at room temperature on a multiphoton microscope (Radiance 2100/AGR-3Q; Bio-Rad Laboratories) with a 40x 0.6 NA objective using LS2000 software (Bio-Rad Laboratories). Images are presented after digital adjustment of curve levels (gamma) to maximize signal. In all cases, exposure times and digital manipulation were the same for control and experimental samples. Fluorochromes and color are as indicated in the figure legends.
###end p 65
###begin title 66
Western blot analysis
###end title 66
###begin p 67
###xml 623 630 610 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
Lysates were prepared by incubating cells in 20 mM Tris HCl, pH 8, 137 mM NaCl, 10% glycerol, 1% NP-40, and 10 mM EDTA on ice for 15 min, cleared by centrifugation, frozen in dry ice, and thawed at 4degreesC. 20 mug per lane of lysates were resolved by SDS-PAGE (4-12% or 8-16% gradient gels; Invitrogen), transferred onto polyvinylidene fluoride membranes (Immobilon-P; Millipore), and probed overnight at 4degreesC with primary antibodies; specific bands were then detected using HRP-conjugated secondary antibodies (1:20,000; GE Healthcare) and the ECL detection system (GE Healthcare). Primary antibodies are listed in Table I.
###end p 67
###begin title 68
Cell cycle analysis
###end title 68
###begin p 69
###xml 78 97 78 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Schmid et al., 1991</xref>
###xml 385 386 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 310 315 <span type="species:ncbi:10090">mouse</span>
###xml 362 366 <span type="species:ncbi:9925">goat</span>
The cell cycle profile of cardiac cells was analyzed as described previously (Schmid et al., 1991). In brief, cells were fixed for 1 h at 4degreesC with 0.25% PFA and then permeabilized for 15 min at 37degreesC with 0.2% Tween 20 before incubation with MF20 and secondary antibodies (Alexa 488-conjugated anti-mouse Ig) diluted 1:100 in FACS buffer (PBS with 1% goat serum and 0.1% NaN3). Cells were then stained with 10 mug/ml propidium iodide in FACS buffer supplemented with 500 mug/ml of RNAase A.
###end p 69
###begin title 70
Online supplemental material
###end title 70
###begin p 71
###xml 66 69 66 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
###xml 171 174 171 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
Fig. S1 shows the incidences of cell cycle entry in response to N2ICD, PHE, and 10% FCS. Fig. S2 shows the presence of mitotic figures in cardiomyocytes treated with Ad-N2ICD. Online supplemental material is available at .
###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
[Supplemental Material Index]
###end title 73
###begin p 74
###xml 233 236 233 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ICD</sub>
We thank Yoav Altman and Ed Monosov (Burnham Institute for Medical Research Shared Resources), and Maria Luisa de la Puerta and Maria del Carmen Rodriguez (Universidad de Valladolid) for expert advice and technical support. The Ad-N2ICD virus was provided by Tom Maciag, whose passing we regret.
###end p 74
###begin p 75
M. Mercola gratefully acknowledges support from National Heart Lung and Blood Institute (grants R37 HL059502-10 and R01 HL083463-01) and a sponsored research agreement from Exelixis, Inc.
###end p 75

